Closing the Bayer Loophole: Sounghun Lee Edited By: This is reflected in 35 U.
Find out what's happening in the world as it unfolds. Petersburg, Indiana CNN When Christina Potts was looking for permanent birth control, she said, her doctor was a "cheerleader" for one option and one option only: Potts says the device, which is implanted in a woman's fallopian tubes to block sperm from reaching an egg, left her in terrible pain and extremely fatigued.
It was so bad that she had a hysterectomy, removing her uterus and tubes to get rid of Essure. Bayer to stop selling Essure birth control device in US Last week, the US Food and Drug Administration expressed safety concerns about Essure, and Bayer Pharmaceuticals announced that it would pull the device off the market at the end of the year.
Potts says she'll always wonder this: Did her former gynecologist recommend Essure because it was best for her or because Bayer paid the doctor tens of thousands of dollars?
These payments are legal but very controversial. Potts' doctor was one of the highest earners, according to federal data.
The financial information comes from a federal database that covers August through the end of last year. Basinski said she also received payments related to Essure for about five years before that, but the database doesn't go back that far, and Basinski says she doesn't remember what she Bayer an analysis paid during those years.
Basinski says she's so convinced of Essure's safety that she'll continue to implant it into women until the device comes off the market. Cindy Basinski said "I did a lot of work to earn that money. A majority of activities were involved with educating physicians.
In those studies, the payments are typically much more modest than what Basinski has received.
But the gynecologist said her clinical judgment hasn't been swayed by the money. She said she could have earned the same amount if she'd been seeing patients during the hours she was paid by Bayer to educate doctors about the device and how to implant it.
I did a lot of work to earn that money," she said. Bayer announced last week that declining sales is the reason it will pull the device off the market and that it stands by the safety of its product.
But according to a US Food and Drug Administration statement put out the same day, the device has been associated with "serious risks including persistent pain, perforation of the uterus and fallopian tubes, and migration of the coils into the pelvis or abdomen.
Essure has been on the market for more than 15 years and has been successfully used by hundreds of thousands of women. Their private Facebook group, Essure Problems, has more than 37, members, including more than 12, women who say they've had a hysterectomy or other surgical procedure to remove the device, according to group founder Angie Firmalino.
With four children -- they have an older daughter and son -- their family was complete. Potts, then 27, asked Basinski about getting her fallopian tubes tied, but she says Basinski told her that wasn't a good choice for a woman with four young children, because it involved recovery time from the surgery.
Essure could be implanted vaginally right in the office, in a procedure much like a routine Pap smear. Christina Potts had a hysterectomy to remove her Essure device. Potts said that's why she didn't call Basinski when she developed headaches, joint pain, abdominal cramping and extreme fatigue about a year after she got the implant.
She said she felt so sick that she had to rely on her oldest child, then 8, to help with her three younger children. Since the hysterectomy, her symptoms have almost completely gone away, she said. Potts says she's angry that, in her memory, Basinski dismissed having her tubes tied, also known as tubal ligation, the other option for permanent female birth control.
She felt "violated" because she felt that her choice was taken away. Basinski's decision, more or less, because she said that this was best, and I wasn't really given another option," she said. Basinski said she couldn't recall her conversation with Potts, but said she felt Potts was not remembering the conversation correctly.
She said she routinely gives patients options for sterilization procedures.
Another patient said Basinski also dismissed tubal ligation as an option in favor of Essure. That patient, who requested not to be named to protect her privacy, later went to a different doctor to have a hysterectomy to remove the device.
Basinski says that if it seems to her patients that she stresses Essure, that's only because it's a relatively new device -- it was approved by the FDA in -- and so it requires more explanation.Hey guys, here is an analysis for Bayer.
Bayer is a global company which act in healthcare and agriculture sectors with huge profit and this sector is good to invest, BUT. About caninariojana.com caninariojana.com is a collaborative research and analysis website that combines the sum of the world's knowledge to produce the highest quality research reports for over 6, stocks, ETFs, mutual funds, currencies, and commodities.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR EUR in weekly data.
Warren Buffett’s Best Dividend Stocks - May 16, These 3 dividend stocks have both growth and income on tap, and are among Warren Buffett's picks that other investors should consider. BAYER AG A Financial Analysis Executive Summary This paper tries to analyse the financial strength of Bayer AG and the other aspects associated with its capital structure and dividend policy.
Bayer Philippines, Inc. is a subsidiary of Bayer AG Germany that has 4 main business units – health/consumer care, chemicals, polymers and agriculture. Among the 4 divisions, the Consumer Care division is the biggest with three major business units: Insect .